Globus Stock Analysis
GMED Stock | USD 49.65 0.60 1.19% |
The main objective of Globus Medical stock analysis is to determine its intrinsic value, which is an estimate of what Globus Medical is worth, separate from its market price. There are two main types of Globus Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Globus Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Globus Medical's stock to identify patterns and trends that may indicate its future price movements.
The Globus Medical stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Globus Medical is usually not traded on Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Veterans Day ( substitute day ), Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday. Globus Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Globus Medical's ongoing operational relationships across important fundamental and technical indicators.
Globus |
Globus Stock Analysis Notes
About 99.0% of the company shares are owned by institutional investors. The book value of Globus Medical was currently reported as 19.76. The company has Price/Earnings To Growth (PEG) ratio of 2.93. Globus Medical had not issued any dividends in recent years. Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people. To learn more about Globus Medical call David Paul at 610 930 1800 or check out https://www.globusmedical.com.Globus Medical Quarterly Cost of Revenue |
|
Globus Medical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Globus Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Globus Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Globus Medical generated a negative expected return over the last 90 days | |
Globus Medical is unlikely to experience financial distress in the next 2 years | |
Globus Medical has a poor financial position based on the latest SEC disclosures | |
Over 99.0% of the company shares are owned by institutional investors | |
Latest headline from news.google.com: Spinal Fusion Devices Market worth 12.99 Billion by 2030 - Exclusive Report by The Insight Partners - Benzinga |
Globus Medical Upcoming and Recent Events
Earnings reports are used by Globus Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Globus Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
14th of November 2023 Upcoming Quarterly Report | View | |
20th of February 2024 Next Financial Report | View | |
30th of September 2023 Next Fiscal Quarter End | View | |
20th of February 2024 Next Fiscal Year End | View | |
30th of June 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Globus Largest EPS Surprises
Earnings surprises can significantly impact Globus Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2015-11-03 | 2015-09-30 | 0.25 | 0.28 | 0.03 | 12 | ||
2014-10-30 | 2014-09-30 | 0.21 | 0.24 | 0.03 | 14 | ||
2014-02-26 | 2013-12-31 | 0.22 | 0.25 | 0.03 | 13 |
Globus Medical SEC Filings
SEC filings are important regulatory documents required of all public companies to provide to potential investors. Globus Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Globus Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Globus Medical specific information freely available to individual and institutional investors to make a timely investment decision.
11th of September 2023 Unclassified Corporate Event | View | |
7th of September 2023 Unclassified Corporate Event | View | |
1st of September 2023 Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets | View | |
3rd of August 2023 Financial Statements and Exhibits. Results of Operations and Financial Condition | View | |
8th of June 2023 Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View | |
4th of May 2023 Financial Statements and Exhibits. Results of Operations and Financial Condition | View | |
3rd of May 2023 Other Events | View | |
27th of April 2023 Financial Statements and Exhibits. Other Events. Submission of Matters to a Vote of Security Holders | View |
Globus Medical Thematic Classifications
In addition to having Globus Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Medical EquipmentUSA Equities from Medical Equipment industry as classified by Fama & French | |
![]() | Obamacare RepealLarge healthcare related equities associated with Obamacare | |
![]() | ObamacareCompanies that count on Obamacare to take off | |
![]() | Baby Boomer ProspectsMega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force |
Globus Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Globus Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Globus Medical backward and forwards among themselves. Globus Medical's institutional investor refers to the entity that pools money to purchase Globus Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last Transaction | Type | Shares | Value | Vanguard Group Inc | 2023-06-30 | Common Shares | 7.5 M | 447.3 M | Blackrock Inc | 2023-06-30 | Common Shares | 7.4 M | 438 M | Janus Henderson Group Plc | 2023-06-30 | Common Shares | 7.1 M | 422.2 M | Nuance Investments Llc | 2023-06-30 | Common Shares | 2.6 M | 157.5 M | Capital Research Global Investors | 2022-12-31 | Common Shares | 2 M | 148.2 M | State Street Corp | 2023-06-30 | Common Shares | 2.4 M | 141.1 M | William Blair Investment Management Llc | 2023-06-30 | Common Shares | 2.3 M | 135.3 M | Wellington Management Group Llp | 2023-06-30 | Common Shares | 2.2 M | 132.5 M | Jpmorgan Chase Co | 2023-06-30 | Common Shares | 1.9 M | 113.1 M | Champlain Investment Partners Llc | 2023-06-30 | Common Shares | 1.7 M | 101.4 M | Gwk Investment Management Llc | 2023-06-30 | Common Shares | 1.7 M | 100.6 M |
Globus Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Globus Medical's market, we take the total number of its shares issued and multiply it by Globus Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Globus Profitablity
Globus Medical's profitability indicators refer to fundamental financial ratios that showcase Globus Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Globus Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Globus Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Globus Medical's profitability requires more research than a typical breakdown of Globus Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23. Last Reported | Projected for 2023 | ||
Return on Investment | 12.71 | 18.57 | |
Return on Average Assets | 0.1 | 0.10 | |
Return on Average Equity | 0.11 | 0.11 | |
Return on Invested Capital | 0.16 | 0.20 | |
Return on Sales | 0.22 | 0.22 |
Management Efficiency
Globus Medical has return on total asset (ROA) of 0.0751 % which means that it generated a profit of $0.0751 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1109 %, meaning that it created $0.1109 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. Globus Medical Return on Average Assets are projected to slightly decrease based on the last few years of reporting. The past year's Return on Average Assets were at 0.1. The current year's Return on Average Equity is expected to grow to 0.11, whereas Return on Sales is forecasted to decline to 0.22. Globus Medical Revenue to Assets are projected to slightly decrease based on the last few years of reporting. The past year's Revenue to Assets were at 0.49. The current year's Total Assets Per Share is expected to grow to 22.36, whereas Current Assets are forecasted to decline to about 881.4 M.Last Reported | Projected for 2023 | ||
Book Value per Share | 18.38 | 15.94 | |
Enterprise Value over EBIT | 32.00 | 31.37 | |
Enterprise Value over EBITDA | 24.51 | 23.94 | |
Price to Book Value | 4.02 | 4.29 | |
Tangible Assets Book Value per Share | 18.07 | 15.58 | |
Enterprise Value | 7.3 B | 6.1 B | |
Tangible Asset Value | 1.8 B | 1.5 B |
The analysis of Globus Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Globus Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Globus Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Common Stock Total Equity 100 K | Income Tax Expense 52.9 M | Interest Expense 14.2 M | Total Operating Expenses 522.9 M | Other Operating Expenses 786.6 M |
Technical Drivers
As of the 2nd of October, Globus Medical retains the Standard Deviation of 1.62, market risk adjusted performance of (0.20), and Risk Adjusted Performance of (0.08). Globus Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Globus Medical, which can be compared to its competitors. Please check out Globus Medical information ratio, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Globus Medical is priced fairly, providing market reflects its last-minute price of 49.65 per share. Given that Globus Medical has information ratio of (0.13), we strongly advise you to confirm Globus Medical's regular market performance to make sure the company can sustain itself at a future point.Globus Medical Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Globus Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Globus Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target..
Globus Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Globus Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Wolterman Dan over three weeks ago Acquisition by Wolterman Dan of 24025 shares of Globus Medical subject to Rule 16b-3 | ||
James Tobin over six months ago Acquisition by James Tobin of 15000 shares of Globus Medical subject to Rule 16b-3 |
Globus Medical Technical and Predictive Indicators
Risk Adjusted Performance | (0.08) | |||
Market Risk Adjusted Performance | (0.20) | |||
Mean Deviation | 1.36 | |||
Coefficient Of Variation | (689.97) | |||
Standard Deviation | 1.62 | |||
Variance | 2.63 | |||
Information Ratio | (0.13) | |||
Jensen Alpha | (0.21) | |||
Total Risk Alpha | (0.17) | |||
Treynor Ratio | (0.21) | |||
Maximum Drawdown | 6.67 | |||
Value At Risk | (2.43) | |||
Potential Upside | 2.38 | |||
Skewness | 0.0443 | |||
Kurtosis | (0.57) |
Risk Adjusted Performance | (0.08) | |||
Market Risk Adjusted Performance | (0.20) | |||
Mean Deviation | 1.36 | |||
Coefficient Of Variation | (689.97) | |||
Standard Deviation | 1.62 | |||
Variance | 2.63 | |||
Information Ratio | (0.13) | |||
Jensen Alpha | (0.21) | |||
Total Risk Alpha | (0.17) | |||
Treynor Ratio | (0.21) | |||
Maximum Drawdown | 6.67 | |||
Value At Risk | (2.43) | |||
Potential Upside | 2.38 | |||
Skewness | 0.0443 | |||
Kurtosis | (0.57) |
Globus Medical Forecast Models
Globus Medical's time-series forecasting models are one of many Globus Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Globus Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Globus Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Globus Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Globus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Globus Medical. By using and applying Globus Stock analysis, traders can create a robust methodology for identifying Globus entry and exit points for their positions.
Last Reported | Projected for 2023 | ||
Operating Margin | 22.29 | 26.27 | |
EBITDA Margin | 0.29 | 0.28 | |
Gross Margin | 0.74 | 0.71 | |
Profit Margin | 0.19 | 0.17 |
Current Globus Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Globus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Globus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
65.73 | Hold | 11 | Odds |
Most Globus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Globus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Globus Medical, talking to its executives and customers, or listening to Globus conference calls.
Globus Stock Analysis Indicators
Globus Medical stock analysis indicators help investors evaluate how Globus Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Globus Medical shares will generate the highest return on investment. By understating and applying Globus Medical stock analysis, traders can identify Globus Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 193.1 M | |
Common Stock Shares Outstanding | 102.6 M | |
Total Stockholder Equity | 1.8 B | |
Total Cashflows From Investing Activities | -110.4 M | |
Tax Provision | 52.9 M | |
Quarterly Earnings Growth Y O Y | 0.075 | |
Property Plant And Equipment Net | 243.7 M | |
Cash And Short Term Investments | 446.1 M | |
Cash | 150.5 M | |
Accounts Payable | 36.1 M | |
Net Debt | -150.5 M | |
50 Day M A | 54.7768 | |
Total Current Liabilities | 159.2 M | |
Other Operating Expenses | 786.6 M | |
Non Current Assets Total | 1.1 B | |
Forward Price Earnings | 32.2581 | |
Common Stock Total Equity | 100 K | |
Non Currrent Assets Other | 43.3 M | |
Stock Based Compensation | 32.8 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide. Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.075 | Earnings Share 1.99 | Revenue Per Share 10.962 | Quarterly Revenue Growth 0.106 | Return On Assets 0.0751 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.